Preview data. People signal currently comes from paper + preprint co-mentions only. X, podcast transcripts, and NIH grant activity roll in over the coming weeks — numbers shown are representative seed fixtures until then.
Mindshare
People Mindshare
Who's shaping the discourse on AI in drug discovery — and whose voice is on the rise.
Share of voice · last 7 days
People Mindshare
Source: Twitter/X, preprint authorship, podcast transcripts, conference programs · biotech.today analysis
Top Gainers
NameCurrentΔ1DΔ7D
- Chris Bahl6.60%▲86.0bps▲190.0bps
- Patrick Walters10.90%▲72.0bps▲147.0bps
- Demis Hassabis17.40%▲58.0bps▲121.0bps
- Pushmeet Kohli1.90%▲42.0bps▲94.0bps
Top Losers
NameCurrentΔ1DΔ7D
- John Jumper4.10%▼68.0bps▼72.0bps
- Jennifer Listgarten2.40%▼42.0bps▼41.0bps
- Mohammed AlQuraishi6.00%▼28.0bps▼34.0bps
Leaderboard
1
David Baker
UW · de novo protein design
91.1
+8.3%
2
Demis Hassabis
Google DeepMind · Isomorphic Labs
85.4
+12.1%
3
Regina Barzilay
MIT · Jameel Clinic
74.3
+6.4%
4
Patrick Walters
Relay · cheminformatics
68.9
+14.7%
5
Sarel Fleishman
Weizmann · antibody design
58.2
+2.8%
6
Chris Bahl
AI Proteins · binder design
49.6
+19.0%
7
Mohammed AlQuraishi
Columbia · protein ML
46.0
-3.4%
Breakdown
By Affiliation
(5)- Academia841
- AI biotech612
- Big pharma204
- Non-profit / gov168
- Independent94
By Expertise
(6)- Structure prediction612
- De novo design498
- Generative chemistry388
- ADMET / PK221
- Antibody design198
- Clinical translation148
By Signal Type
(5)- Twitter posts1,241
- Preprints612
- Podcast appearances214
- Press / interviews186
- Conference talks172